Adagene (ADAG) Enterprise Value (2019 - 2025)
Adagene's (ADAG) quarterly Enterprise Value came in at -$75.8 million in Q4 2025, up 12.8% year-on-year from -$67.2 million in Q4 2024, and down 20.72% on a QoQ basis from -$62.8 million in Q2 2025.
Adagene (ADAG) Enterprise Value (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Enterprise Value data on file, last reported at -$75.8 million in Q4 2025.
- On a quarterly basis, Enterprise Value rose 12.8% year-over-year to -$75.8 million in Q4 2025; TTM through Dec 2025 was -$75.8 million, a 12.8% increase from a year earlier, with the FY2025 full-year figure at -$75.8 million, up 12.8% from the prior year.
- Enterprise Value for Q4 2025 stood at -$75.8 million, down from -$62.8 million in the prior quarter.
- Over the last five years, Enterprise Value for ADAG reached as high as -$128.76 in Q2 2023 and fell as low as -$208.3 million in Q2 2021.
- Historically, Enterprise Value has averaged -$96.4 million across 5 years, with a median of -$91.3 million in 2024.
- Across the five-year window, Enterprise Value jumped 100.0% in 2022 and plunged 74303888.22% in 2024, its largest moves.
- Year by year, Enterprise Value stood at -$176.3 million in 2021, then rose by 16.76% to -$146.7 million in 2022, then rose by 23.86% to -$111.7 million in 2023, then rose by 22.15% to -$87.0 million in 2024, then advanced by 12.8% to -$75.8 million in 2025.
- Per Business Quant data, the three most recent Enterprise Value figures were -$75.8 million in Q4 2025, -$62.8 million in Q2 2025, and -$87.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - | -75.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -75.84 Mn |
| Jun 30, 2025 | -62.83 Mn |
| Dec 31, 2024 | -86.97 Mn |
| Jun 30, 2024 | -95.67 Mn |
| Dec 31, 2023 | -111.72 Mn |
| Jun 30, 2023 | -128.76 |
| Dec 31, 2022 | -146.73 Mn |
| Jun 30, 2022 | -168.04 |
| Dec 31, 2021 | -176.27 Mn |
| Jun 30, 2021 | -208.27 Mn |
| Dec 31, 2020 | -76.80 Mn |
| Dec 31, 2019 | -93.50 Mn |